PT  - JOURNAL ARTICLE
AU  - Kurita, Junko
AU  - Sugawara, Tamie
AU  - Ohkusa, Yasushi
TI  - Rule of thumb in human intelligence for assessing the COVID-19 outbreak in Japan
AID  - 10.1101/2021.01.20.21250204
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.20.21250204
4099  - http://medrxiv.org/content/early/2021/01/26/2021.01.20.21250204.short
4100  - http://medrxiv.org/content/early/2021/01/26/2021.01.20.21250204.full
AB  - Background The COVID-19 outbreak in Japan exhibited its third peak at the end of 2020. Mathematical modelling and developed AI cannot explain several peaks in a single year.Object This study was conducted to evaluate a rule of thumb for prediction from past wave experiences.Method We rescaled the number of newly infected patients as 100% at the peak and checked similarities among waves. Then we extrapolated the courses of the third and later waves.Results Results show some similarity around the second and the third waves. Based on this similarity, we expected the bottom of the third wave will show 2131 newly positive patients including asymptomatic patients at around the end of February, 2021.Discussion and Conclusion We can infer the course of the third wave from similarity with the second wave. Mathematical modelling has been unable to do it, even when AI was used for prediction. Performance of the rule of thumb used with human intelligence might be superior to that of AI under these circumstances.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All information used for this study has been published. There is therefore no ethical issue related to this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan: COVID-19 Public Forecasts https://datastudio.google.com/u/0/reporting/8224d512-a76e-4d38-91c1-935ba119eb8f/page/ncZpB